| Literature DB >> 23400040 |
Murat Topbaş1, Sükrü Ozgün, Müjgan F Sönmez, Ayşe Aksoy, Gamze Can, Asuman Yavuzyilmaz, Emine Can.
Abstract
OBJECTIVE: Epilepsy is a most common serious neurological disorder and is one of the world's most prevalent non-communicable diseases. The aim of this study was to determine the prevalence and risk factors of epilepsy in 0-17 year old children in Trabzon, Turkey.Entities:
Keywords: Epilepsy; Neurological Disorder; Prevalence; Risk Factor
Year: 2012 PMID: 23400040 PMCID: PMC3564090
Source DB: PubMed Journal: Iran J Pediatr ISSN: 2008-2142 Impact factor: 0.364
Participants’ crude and age–adjusted epilepsy prevalences (Trabzon, 2007)
| Age groups (years) | Prevalence of epilepsy | Segi (world) standard | Scandinavian (European) standard | WHO world standard |
|---|---|---|---|---|
| 0-4 | 5.1 | 0.61 | 0.41 | 0.45 |
| 5-9 | 7.5 | 0.75 | 0.53 | 0.65 |
| 10-14 | 15.3 | 1.38 | 1.07 | 1.32 |
| 15-17 | 3.3 | 0.18 | 0.14 | 0.17 |
| Total | 8.6 | 3.14 | 2.26 | 2.69 |
Per 1000
Epilepsy prevalence by various socio-demographic characteristics (Trabzon, 2007)
| Characteristics | Prevalence of epilepsy | 95% CI |
| Odds Ratio | ||||
|---|---|---|---|---|---|---|---|---|
| n | n |
| Lower | Upper | ||||
|
| 0-4 | 1181 | 6 |
| 1.0 | 9.2 | 0.01 | 1 |
| 5-9 | 1198 | 9 |
| 2.6 | 12.4 | 1.48 | ||
| 10-14 | 1304 | 20 |
| 8.6 | 22.0 | 3.05 | ||
| 15-17 | 605 | 2 |
| 0.0 | 7.9 | 0.65 | ||
|
| Female | 2104 | 19 |
| 5.0 | 13.0 | 0.9 | |
| Male | 2184 | 18 |
| 4.4 | 12.0 | |||
|
| Illiterate | 227 | 5 |
| 2.9 | 41.1 | 0.1 | 1.00 |
| Primary school (5 years) | 2235 | 22 |
| 5.7 | 13.9 | 0.44 | ||
| Middle school (8 years) | 482 | 3 |
| 0.0 | 13.2 | 0.28 | ||
| High school (11 years) | 996 | 6 |
| 1.2 | 10.8 | 0.27 | ||
| University (13-17 years) | 346 | 1 |
| 0.0 | 8.6 | 0.13 | ||
|
| Illiterate | 37 | 0 |
| 0.0 | 0.0 | 0.4 | |
| Primary school (5 years) | 1297 | 15 |
| 5.8 | 17.4 | |||
| Middle school (8 years) | 661 | 4 |
| 0.2 | 12.0 | |||
| High school (11 years) | 1422 | 14 |
| 4.7 | 14.9 | |||
| University (13-17 years) | 836 | 4 |
| 0.1 | 9.5 | |||
|
| Minimum wage and below | 635 | 13 |
| 9.5 | 31.5 | 0.001 | |
| Above minimum wage | 3606 | 24 |
| 0.0 | 0.4 | |||
|
| Not working (Housewife) | 3741 | 33 |
| 5.8 | 11.8 | 1 | |
| Working | 547 | 4 |
| 0.2 | 14.4 | |||
|
| 1st Degree Relatives | 363 | 4 |
| 0.3 | 21.7 | 0.8 | |
| 2nd Degree relatives | 163 | 1 |
| 0.0 | 18.1 | |||
| Not Related by Blood | 3754 | 32 |
| 5.6 | 11.4 | |||
Epileptic children's epilepsy type, age at onset and time spent as epileptic patient
| Parameter | Definition | n | % |
|---|---|---|---|
|
| Tonic clonic | 24 | 64.9 |
| Myoclonic | 10 | 27.0 | |
| Absence | 9 | 24.3 | |
| Atonic | 7 | 18.9 | |
| Complex Partial | 5 | 13.5 | |
| Simple Partial | 4 | 10.8 | |
| Tonic | 4 | 10.8 | |
|
| <1 year | 11 | 29.7 |
| 1-4 years | 17 | 45.9 | |
| 5-9 years | 5 | 13.5 | |
| ≥ 10 years | 4 | 10.8 | |
|
| 1-4 years | 20 | 54.1 |
| 5-9 years | 9 | 24.3 | |
| ≥10 years | 8 | 21.6 |
* Calculated according to number of epileptic individuals (n=37)
Distribution of various risk factors in normal and epileptic individuals
| Risk Factors | Epilepsy (n=37) n (%) | Normal (n=4251) n (%) |
| |
|---|---|---|---|---|
|
| Drug Use | 3 (8.1) | 728 (17.1) | 0.2 |
| Disease | 2 (5.4) | 235 (5.5) | 1 | |
| Hemorrhage | 3 (8.1) | 95 (2.2) | 0.06 | |
|
| Jaundice | 12 (32.4) | 933 (21.9) | 0.1 |
| Incubator | 3 (8.1) | 276 (6.5) | 0.7 | |
| Bruising | 4 (10.8) | 227 (5.3) | 0.3 | |
| No crying | 4 (10.8) | 199 (4.7) | 0.2 | |
| Cord entanglement | 1 (2.7) | 99 (2.3) | 1 | |
| Health Personnel Unassisted Birth | 1 (2.7) | 55 (1.3) | 0.3 | |
| Neonatal convulsion | 5 (13.5) | 36 (0.8) | <0.0005 | |
|
| Febrile Convulsion | 4 (10.8) | 120 (2.8) | 0.02 |
| Heat Trauma | 3 (8.1) | 68 (1.6) | 0.01 | |
| Meningitis | 2 (5.4) | 14 (0.3) | <0.0005 | |
|
| Epilepsy | 10 (27.0) | 307 (7.2) | <0.0005 |
| Febrile Convulsion | 6 (16.2) | 598 (14.1) | 0.7 | |
| MMR | 1 (2.7) | 158 (3.7) | 1 | |
Epilepsy prevalences in different countries
| Study | Country | Age Group | Year | Prevalence or incidence* per 1000 |
|---|---|---|---|---|
|
| England | 0-23 | 1998 | 8.4* |
|
| Finland | 0-15 | 1992 | 3.9 |
|
| Malatya (Turkey) | 7-12 | 2001 | 8.0 |
|
| India | 6-15 | 1997 | 4.2 |
|
| Lithuania | 0-15 | 1995 | 4.3 |
|
| Estonia | 5-9 | 1999 | 4.3 |
|
| Norway | 6-12 | 2000 | 5.1 |
|
| Pakistan | 0-10 | 1997 | 9.98 |
|
| Turkey | 0-10 | 1997 | 7.0 |
|
| Hong Kong | <19 | 2004 | 4.3 |
|
| Switzerland | 0-16 | 1996 | 4.2 |
|
| Turkey | 0-16 | 2004 | 8.0 |
|
| India | ≤19 | 2003-4 | 7.0 |
|
| Cameroon | 10-19 | 2004 | 26.1 |
|
| Trabzon / Turkey | 0-17 | 2007 | 8.6 |